Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.71
-0.12 (-1.53%)
At close: Mar 6, 2026, 4:00 PM EST
7.77
+0.06 (0.78%)
After-hours: Mar 6, 2026, 7:34 PM EST
Gyre Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Gyre Therapeutics stock have an average target of 17, with a low estimate of 16 and a high estimate of 18. The average target predicts an increase of 120.49% from the current stock price of 7.71.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 10, 2025.
Analyst Ratings
The average analyst rating for Gyre Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|
| Strong Buy | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +107.52% | Oct 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +133.46% | Aug 26, 2025 |
Financial Forecast
Revenue This Year
118.01M
from 105.76M
Increased by 11.59%
Revenue Next Year
149.06M
from 118.01M
Increased by 26.31%
EPS This Year
0.19
from 0.05
Increased by 288.95%
EPS Next Year
0.19
from 0.19
Increased by 1.82%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 122.4M | 207.9M | ||||
| Avg | 118.0M | 149.1M | ||||
| Low | 112.7M | 112.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 15.8% | 76.2% | ||||
| Avg | 11.6% | 26.3% | ||||
| Low | 6.6% | -5.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 0.23 | 0.45 | ||||
| Avg | 0.19 | 0.19 | ||||
| Low | 0.15 | 0.02 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 380.5% | 141.4% | ||||
| Avg | 289.0% | 1.8% | ||||
| Low | 205.8% | -89.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.